OSIMERTINIB vs OXALIPLATIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OSIMERTINIB vs OXALIPLATIN: Safety Overview
| Metric | OSIMERTINIB | OXALIPLATIN |
|---|---|---|
| Total FAERS Reports | 27,750 | 56,406 |
| Deaths Reported | 12,456 | 6,501 |
| Death Rate | 44.9% | 11.5% |
| Hospitalizations | 5,277 | 21,980 |
| Average Patient Age | 68.2 yrs | 61.5 yrs |
| % Female Patients | 66.0% | 42.1% |
| FDA Approval Date | Nov 13, 2015 | Apr 28, 2011 |
| Manufacturer | AstraZeneca Pharmaceuticals LP | Camber Pharmaceuticals, Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | Discontinued |